NRx Pharmaceuticals (NRXP) Institutional Ownership $1.57 +0.15 (+10.56%) (As of 05:19 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for NRx Pharmaceuticals (NASDAQ:NRXP)CurrentInstitutional OwnershipPercentage4.27%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$36.29MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$1.54M Get NRXP Insider Trade Alerts Want to know when executives and insiders are buying or selling NRx Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NRXP Institutional Buying and Selling by Quarter Ad InvestorPlaceWall St. Icon: “If you wait on this, it will already be too late”If you have a significant amount of money in the stock market right now — or if you're sitting on the sidelines waiting to make a move — you DO NOT want to miss my latest research.Go here now to see my urgent warning NRx Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 Anson Funds Management LP142,525$241K0.0%N/A1.326% 11/13/2024 Townsquare Capital LLC15,041$25K0.0%N/A0.140% 8/8/2024 AdvisorShares Investments LLC108,085$279K0.0%-82.4%1.010% 8/6/2024 One Wealth Management Investment & Advisory Services LLC15,041$37K0.0%-89.3%0.141% 2/14/2024 AdvisorShares Investments LLC642,632$296K0.1%N/A0.755% 1/25/2024 One Wealth Management Investment & Advisory Services LLC140,402$65K0.0%N/A0.165% Get the Latest News and Ratings for NRXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NRx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/15/2023 Sabby Management LLC325,000$84K0.1%-53.6%0.398% 5/1/2023 Virtu Financial LLC46,210$30K0.0%N/A0.065% 2/9/2023 HBK Sorce Advisory LLC58,460$65K0.0%N/A0.086% 1/31/2023 AE Wealth Management LLC29,515$33K0.0%N/A0.044% 1/27/2023 Exchange Traded Concepts LLC26,924$30K0.0%+154.0%0.040% 1/18/2023 Exchange Traded Concepts LLC26,924$30K0.0%+154.0%0.040% 11/3/2022 Texas Capital Bank Wealth Management Services Inc.63,290$47K0.0%N/A0.094% 5/18/2022 Ursa Fund Management LLC15,000$37K0.0%N/A0.023% 4/29/2022 United Asset Strategies Inc.18,300$45K0.0%N/A0.027% 2/9/2022 Wolverine Asset Management LLC37,105$177K0.0%-12.8%0.063% 2/8/2022Raymond James Financial Services Advisors Inc.11,567$55K0.0%N/A0.020% 11/15/2021 Penserra Capital Management LLC2,956$27K0.0%N/A0.005% 11/12/2021 Wolverine Asset Management LLC42,568$394K0.0%+118.4%0.079% 11/5/2021 Advisor Group Holdings Inc.42,885$398K0.0%+1,197.6%0.080% 11/2/2021 Cambridge Investment Research Advisors Inc.153,523$1.42M0.0%N/A0.285% 8/16/2021 Owl Creek Asset Management L.P.300,000$3.40M0.2%N/A0.626% 8/16/2021 Ionic Capital Management LLC35,721$415K0.0%N/A0.075% 8/16/2021 Linden Advisors LP364,352$4.23M0.0%N/A0.760% 8/13/2021 Northern Trust Corp130,633$1.52M0.0%N/A0.273% 8/13/2021 Yakira Capital Management Inc.11,923$139K0.0%N/A0.025% 8/13/2021 Geode Capital Management LLC34,475$400K0.0%N/A0.072% 8/13/2021 Vanguard Group Inc.637,416$7.41M0.0%N/A1.330% (Data available from 1/1/2016 forward) NRXP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NRXP shares? During the previous two years, 9 institutional investors and hedge funds held shares of NRx Pharmaceuticals. The most heavily invested institutionals were AdvisorShares Investments LLC ($279K), Anson Funds Management LP ($241K), Sabby Management LLC ($84K), HBK Sorce Advisory LLC ($65K), One Wealth Management Investment & Advisory Services LLC ($37K), AE Wealth Management LLC ($33K), and Virtu Financial LLC ($30K).Learn more on NRXP's institutional investors. What percentage of NRx Pharmaceuticals stock is owned by institutional investors? 4.27% of NRx Pharmaceuticals stock is owned by institutional investors. Learn more on NRXP's institutional investor holdings. Which institutional investors have been buying NRx Pharmaceuticals stock? The following institutional investors have purchased NRx Pharmaceuticals stock in the last 24 months: AdvisorShares Investments LLC ($642.63K), Anson Funds Management LP ($142.53K), One Wealth Management Investment & Advisory Services LLC ($140.40K), HBK Sorce Advisory LLC ($58.46K), Virtu Financial LLC ($46.21K), Exchange Traded Concepts LLC ($32.64K), and AE Wealth Management LLC ($29.52K). How much institutional buying is happening at NRx Pharmaceuticals? Institutional investors have bought a total of 1,107,429 shares in the last 24 months. This purchase volume represents approximately $52.72M in transactions. Which NRx Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold NRx Pharmaceuticals stock in the last 24 months: AdvisorShares Investments LLC ($506.71K), Sabby Management LLC ($374.73K), and One Wealth Management Investment & Advisory Services LLC ($125.36K). How much institutional selling is happening at NRx Pharmaceuticals? Institutional investors have sold a total of 1,006,800 shares in the last 24 months. This volume of shares sold represents approximately $11.29M in transactions. Related Companies Immuneering Major Shareholders BeyondSpring Major Shareholders Prelude Therapeutics Major Shareholders DBV Technologies Major Shareholders Ovid Therapeutics Major Shareholders Clearside Biomedical Major Shareholders Viveon Health Acquisition Major Shareholders Cue Biopharma Major Shareholders SELLAS Life Sciences Group Major Shareholders OptiNose Major Shareholders This page (NASDAQ:NRXP) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredSix Stocks That Could Soar on Trump’s First Day BackThe recent election results have clarified a path forward, creating opportunities that weren't as clear just m...InvestorPlace | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NRx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.